Objective: Smooth muscle cell (SMC) migration and proliferation are the key steps in the development of atherosclerosis and restenosis. Matricellular proteins have been implicated in cell adhesion, migration and proliferation. Here we investigated the role of the matricellular protein galectin-1 (Gal-1), a b-galactoside-binding lectin, in SMC proliferation in atheroma and DNA synthesis in cell culture. Methods: Protein expression was visualised by tissue section immunostaining. RNA expression was analysed using Northern blot 3 analysis. DNA synthesis of human vascular SMCs was determined by H-thymidine incorporation. Recombinant glutathione Stransferase-galectin-1 fusion protein (Gal FP) binding to extracellular matrix (ECM) proteins was measured by ELISA. Gal-1 binding to 125 cells and ECM was estimated using I-labelled Gal FP. Results: Prominent Gal-1 staining coincided with SMC proliferation in human coronary endarterectomy samples in organoid culture. In cell culture, Gal-1 mRNA was upregulated in growing SMCs. Gal FP increased serum-induced DNA synthesis of human SMCs on plastic or endogenous ECM, but not of a rat PAC1 SM cell line. Also, Gal FP slightly increased SMC adhesion to ECM. SMCs exhibited a complex pattern of receptor-ligand interactions with Gal FP. The Gal-1 binding to SMCs was much stronger than to ECM, produced by these SMCs. We identified new ECM proteins: thrombospondin, vitronectin and osteopontin, which bound to Gal FP in a dose-and b-galactoside-dependent manner in ELISA. Conclusions: Gal-1 binding to SMCs was stronger than to ECM, although ECM of atherosclerotic blood vessels contained additional ECM proteins which bound to Gal-1. Gal-1 was upregulated during SMC growth and Gal FP enhanced serum-induced DNA synthesis in SMCs. Overall, Gal-1 upregulation is likely to provide a reinforcement of serum-induced events during vascular injury.
Introduction
adhesion is involved in the regulation of cell proliferation per se, and in cell proliferation stimulated by growth Vascular smooth muscle cells (SMCs) play a critical role factors [3, 4] . Normal non-transformed cells must adhere to in the normal and pathological responses of the arterial ECM components in order to proliferate in vitro. This wall to injury. They are normally present in the arterial phenomenon is called anchorage-dependence for the protunica media in the resting state. Vascular injury causes gression of the cell cycle. The repertoire of integrins and proliferation of these cells and their subsequent migration composition of ECM determine whether a cell will surfrom media to intima, where they proliferate and deposit vive, proliferate or exit the cell cycle and differentiate in extracellular matrix (ECM). A combination of migration response to soluble growth factors. A particular subset of and proliferation of SMCs plays an important role in the integrins, a1b1 (collagen / laminin receptor), a5b1 (fibropathogenesis of a number of cardiovascular diseases, nectin receptor), and avb3 (broad specificity RGD reincluding atherosclerosis and restenosis after angioplasty ceptor), were shown to link cell adhesion to the MAP and coronary stenting [1, 2] .
kinase pathway and cell proliferation in response to An increasing number of studies have shown that cell mitogens in primary endothelial cells and several other cell types [5, 6] . is necessary for the expression of cyclin D and A, and the phage CD68 antigen and SM a-actin were purchased from activation of cyclinD-cdk4 / 6 and cyclinE-cdk2 complexDako. es required for cell cycle progression from G0 to S phase [7] [8] [9] .
2.2. Tissue preparation Recently, a new class of matricellular proteins have been implicated in cell adhesion, migration and proliferation Three coronary endarterectomy samples were obtained [10] . Matricellular proteins, such as thrombospondin from patients undergoing coronary artery bypass graft (TSP), osteopontin (OSP), SPARC etc., interact with ECM surgery. The investigation conforms with the principles proteins and cellular receptors, and thereby modify ECMoutlined in the Declaration of Helsinki (Cardiovascular dependent cell responses. Recently, we showed that Research 1997;35:2-3). Organoid culture was described galectin-1 (Gal-1), a small b-galactoside-binding lectin, previously [19, 20] . Briefly, the tissue samples were cut exhibited some properties of matricellular proteins. Gal-1 into segments. A preculture control was fixed immediately, affected adhesion and migration of SMCs in cell culture by the other segments of tissue were cultured up to 10 days in interacting with a1b1 integrins and ECM proteins laminin RMPI 1640 (Gibco BRL) medium containing 30% foetal (LN), and cellular fibronectin (cFN) [11] .
bovine serum (FBS), antibiotics and 2 mM of L-glutamine, Gal-1 is a ubiquitous mammalian protein expressed in then fixed in formol saline. Paraffin tissue sections were many tissues at low levels, but particularly abundant in prepared and processed as usual, stained with rabbit skeletal, cardiac and smooth muscle [12] [13] [14] . Previously, antibody against Gal-1 and monoclonal antibodies against this protein was shown to affect proliferation of non-PCNA, SM a-actin and macrophage CD68 antigen, folvascular cell types [15] [16] [17] [18] . The published data on the lowed by secondary biotinylated antibodies, detected with effect of Gal-1 on cell proliferation are contradictory. It AB complex / HRP (Dako) and 3,39-diaminoazobenzidine inhibited growth of mouse embryo fibroblasts, but stimuas a substrate for HRP. Some sections were counter-stained lated proliferation of the mouse fibroblast BALB3T3 cell in Mayer's hematoxylin. The primary antibody was omitline. Gal-1 also inhibited or stimulated cell growth of some ted from the negative controls. types of tumour cells, depending on the Gal-1 concentrations. However, transformed and tumour cells have a 2.3. Cell lines deregulated cell cycle and very often lose anchoragedependence of cell proliferation.
The investigation conforms with the principles outlined Here we investigated whether Gal-1 was involved in in the Declaration of Helsinki. Human vascular smooth proliferation of human vascular SMCs in cell and organoid muscle cells originated from primary explant culture of culture and analysed Gal FP binding to SMCs and to ECM saphenous vein fragments, which were obtained from proteins selectively expressed in atherosclerotic blood patients undergoing coronary bypass grafting, and cultured vessels. Our data suggested that Gal-1 was upregulated in DMEM medium with 20% FBS as described previously during serum-induced proliferation of SMCs and enhanced [11] . SMCs of 3-6 passages were used in the study. SMC DNA synthesis in vascular human SMCs.
phenotype was verified by immunostaining with anti-SM a-actin antibody and by a characteristic hill-and-valley growth pattern. These cells were used in most experiments 2. Materials and methods unless stated otherwise. Umbilical SMCs, isolated from human umbilical cord arteries and kindly provided by Dr 2.1. Materials N. Carragher (Yamanouchi Research Institute, Oxford), were cultured in the same way as venous SMCs. The rat The construction of the recombinant protein to fuse PAC1 cell line derived from pulmonary arterial smooth C-terminus of glutathione S-transferase (GST) and Nmuscle was cultured in DMEM medium with 10% FBS terminus of human galectin-1 was described in detail [21, 22] . previously [11] . GST and GST-Gal-1 fusion protein (Gal FP) were purified as described previously [11] . Polyclonal 2.4. mRNA expression analysis anti-Gal-1 and anti-GST antibodies were described previously [11] . Laminin (LN) from basement membrane of Total RNA was isolated from PAC1 cells and human Engelbreth-Holm-Swarm mouse sarcoma, human plasma SMCs using Trizol reagent (GIBCO BRL) according to and cellular fibronectin (pFN and cFN), human vitronectin manufacturer's protocol. Proliferating cells were grown to (VN) were purchased from Sigma-Aldrich; human throm-65-70% confluence in serum containing medium as debospondin (TSP)-from Calbiochem-Novabiochem. Rat scribed above. osteopontin (OSP) was kindly provided by SmithKline
The quiescent cells were prepared as follows: the cells Beecham Pharmaceuticals. Monoclonal antibodies against were grown to confluence and synchronised in G0 phase the proliferating cell nuclear antigen (PCNA) were purby serum starvation in serum-free DMEM supplemented chased from Sigma. Monoclonal antibody against macrowith insulin-transferrin-selenium (Gibco BRL) for 2 days, followed by treatment with 5 ng / ml of TGFb (R&D [ H]-thymidine-labelled SMCs were detached, (10 cells / Systems), 10 ng / ml PDGF BB (Sigma) or 100 nM of well), re-suspended in DMEM containing 1% BSA, were angiotensin II (Sigma) in serum-free DMEM for 3 days.
allowed to adhere to ECM-covered plates for 1 h at 378C, The medium was changed every day. Control quiescent followed by washing the plate with PBS. Adhered cells cells were kept in serum-free DMEM for 5 days altogether.
were dissolved in 1 M NaOH and counted. The radioactivi-3 3
Northern blots with total RNA on Hybond N-membrane ty in controls ranged from 4310 cpm to 13310 cpm in (Amersham) were prepared [23] , hybridised to cDNA different experiments. All data are shown as the means (% probes: human Gal-1 cDNA [11] and human glyceralof control)6SD from at least three experiments conducted dehyde 3-phosphate dehydrogenase (GAPDH) cDNA in eight wells for each variant. (kindly provided by Dr A.J. Woods, University of Leicester, UK), and stripped as described previously [24] . cDNA 2.7. FACScan analysis probes were labelled using Multiprime DNA labelling kit 5 (Amersham). To estimate Gal-1 mRNA expression, we
Detached live non-permeabilized SMCs (8310 / ml) quantified the bands on the autoradiographs using image were incubated with 500 and 1000 ng / ml amounts of GST analysis (AlphaImager 2000, Alpha Innotech Corporation).
or Gal FP in PBS with 1% BSA for 30 min at 158C (to restrict endocytosis), followed by incubation with rabbit 2.5. DNA synthesis anti-GST antibody and FITC-labelled anti-rabbit antibody (Dako), both in dilution 1:100, for 30 min at 158C. The cell Briefly, 96 well plates were coated with either of GST or fluorescence was measured with a FACScan flow cytomeGal FP (300 ng / well) by air-drying, and washed with PBS.
ter (Becton-Dickinson). The data were analysed on a Cells were grown to confluence, synchronised in G0 by Hewlett-Packard (HP9000) computer equipped with FACserum starvation in serum-free DMEM supplemented with Scan research software. Population gates were set using insulin-transferrin-selenium for 48 h, detached and plated SMCs incubated with secondary antibody. GST and Gal FP were labelled using the iodo-gen To study the effect of Gal-1 on DNA synthesis on method: 100 mg of each protein were iodinated with 300 125 endogenous ECM, ECM was prepared as described previmCi of Na I (NEN Life Science Products) according to ously [25] . Briefly, SMCs were grown and kept on 96 well manufacturer's protocol. The specific activity was adjusted 5 plates for 7 days in FBS-containing DMEM; then cells to 1.75310 cpm / mg of proteins. were removed by consecutive washing of the plates on ice SMCs were grown to confluence in 10% FBS medium with hypotonic buffer containing 10 mM Tris-HCl, pH7.5, for 6 days on several identical 24 well plates. These plates 0.1% BSA and 0.1 mM CaCl , followed by the same were used for ECM-and SMC-binding studies. Cell 2 4 buffer with 0.25% NP-40 and washing with PBS. ECM number, averaged among 6 wells, was 3.5310 cells per was incubated with 1% BSA or 300 ng / well of either GST well. To study Gal-1 binding to cells, SMCs were detached or Gal FP in 1% BSA for 1 h at room temperature, washed by trypsinisation and resuspended in DMEM, containing with PBS and used for plating the cells as described above.
1% BSA, followed by incubation with 0.25-12.5 pmol of All data are shown as the means (% of control)6SD
Gal FP (10-500 ng) and GST in 500 ml of DMEM with from at least three experiments conducted in eight wells 1% BSA for 1 h at 158C to restrict endocytosis. After that, for each variant. The 100% of radioactivity in controls cells were washed with PBS, dissolved in 150 ml of RIPA 3 3 ranged from 1.3310 to 2310 cpm / well for human buffer, containing 10 mM Tris-HCl, pH 7.0, 150 mM 3 SMCs and about 4310 cpm / well for PAC1 cells. NaCl, 2 mM EDTA, 0.1% SDS, 1% NP40, 1% sodium To study whether Gal-1 stimulated DNA synthesis deoxycholate, and counted. without serum, SMCs prepared as described above were
To study Gal-1 binding to ECM, ECM was prepared as incubated in serum-free DMEM supplemented with indescribed above. ECM was blocked with 1% BSA in sulin-transferrin-selenium (GIBCO BRL) with 1 mCi / DMEM for 30 min on ice and incubated with 1.25-12.5 3 3
well of [ H]-thymidine for 24 h.
[ H]-thymidine incorporapmol of Gal FP and GST in 500 ml of DMEM that tion was below 500 cpm per well.
contained 1% BSA and protease inhibitors cocktail (Sigma) for 1 h at room temperature, washed with 1% 2.6. Cell attachment assay BSA in DMEM. Bound radioactivity was extracted with 1 M NaOH and counted. To investigate b-galactoside depenTo test whether Gal FP affects SMC adhesion on dent interactions, we carried out the binding assays in the endogenous ECM, we used 96 well plates with ECM, presence of 100 mM lactose. prepared as described above. SMCs were grown in DMEM Gal-1 specific binding was determined as the difference between the values of binding of Gal FP and GST used in the same molar concentrations. All data are presented as darterectomy fragments exposed to serum in organoid the means6SD of six samples. Scatchard analysis of Gal-1 culture. binding to cells was performed by plotting the ratio of To determine whether Gal-1 upregulation occurred at bound / free Gal-1 concentrations against bound Gal-1 the RNA level and to identify the factors inducing Gal-1 concentration. As Gal-1 binding to ECM was low, we expression, we studied expression of Gal mRNA in SMCs could not draw the Scatchard plot for ECM binding.
in cell culture using Northern blotting (Fig. 2) . The levels of Gal-1 mRNA were increased 2-2.5 fold in proliferating cells in three examined SMC types. The treatment of 2.9.
Gal FP binding to ECM proteins in vitro
SMCs with TGFb, PDGF and Ang II increased Gal-1 mRNA levels by 30-40% in human SMCs and the PAC1 ELISA assay was performed as described previously cells. Hence, Gal-1 was upregulated at the mRNA and [11]. Briefly, 96 well plates coated with 300 ng / well of protein levels in growing SMCs exposed to serum in cell ECM proteins were incubated with indicated amounts of and organoid culture. For this reason we suggested that GST or Gal FP in PBS with 1% BSA, washed, incubated
Gal-1 accumulation might have functional importance in with rabbit antibody to GST and secondary HRP-linked SMC proliferation. anti-rabbit antibody, and processed as described previousTo investigate whether Gal-1 was involved in SMC ly. To investigate b-galactoside dependent interactions, the proliferation, we studied DNA synthesis in SMCs in binding assays were carried out in the presence of 50 mM response to serum in the presence of Gal FP in cell culture. lactose. All data are shown as means of four 6SD.
When SMCs were plated on Gal FP-covered plastic, DNA synthesis was increased up to 129% compared to DNA synthesis on plastic or GST-cover plastic (Fig. 3A) . Also, 2.10. Data analysis an increase up to 120% was observed when SMCs were plated on endogenous ECM treated with Gal FP compared Differences among the groups for the combined experiwith ECM non-treated or treated with GST (Fig. 3B) . The ments were prepared using one-way ANOVA in Statistical DNA synthesis was two and a half-fold higher on endogPackage for the Social Sciences, followed by Dunnett's enous ECM than on plastic. Thus, Gal-1 increased DNA test to determine whether the treatment groups were synthesis of human vascular SMCs on both plastic and different from the control group. P,0.05 was selected as endogenous ECM in the presence of serum. In a similar the level of statistical significance. All quantitative data are type of experiment, we studied whether Gal-1 would presented as means6SD, with P values indicated in the increase DNA synthesis of the SM cell line PAC1. Gal FP figure legends.
did not affect DNA synthesis in PAC1 SM cells (Fig. 3) .
To study whether Gal FP has any mitogenic activity, we cultured SMCs in serum-free medium on Gal FP-covered 3. Results plastic or ECM treated with Gal FP. Gal FP did not induce DNA synthesis (not shown). Since cell proliferation is The SM origin of the cells in coronary endarterectomy influenced by cell adhesion, we investigated whether Gal samples was confirmed by immunostaining for SM a-FP would affect SMC adhesion to ECM (Fig. 4) . SMC actin. SMCs stained with antibody against SM a-actin attachment was higher to ECM in all variants compared to were predominant in the media and intima of the tissue plastic. Further treatment of ECM with Gal FP increased samples (Fig. 1) . Macrophages, identified by immunocell adhesion only slightly (108%), whereas treatment with staining for CD68, were found in some, but not all GST did not have any effect. examined sections. CD68-positive macrophages were obOur previous data suggested that Gal-1 interacted with served as scattered cells close to the lumenal surface ( . Using flow (not shown). Gal-1 staining was not observed in preculture cytometry we detected a direct interaction between Gal FP control samples (Fig. 1, Day 0) . A progressive increase in and SMCs that indicated the presence of receptors for Gal-1 staining was observed when coronary endarterecGal-1 on the cell surface. The fluorescence of SMCs tomy samples were cultured in the presence of serum for 4 incubated with a mixture of anti-GST and secondary FITC-(not shown), 7 (Fig. 1) , and 10 days (not shown). The labelled antibodies in the absence or presence of GST was Gal-1 staining was observed mostly at a far distance from very similar, whereas the presence of Gal FP significantly cell nuclei in the ECM of atherosclerotic tissue fragments.
increased SMC fluorescence (Fig. 5) . The treatment of the Limited areas of very strong Gal-1 staining were observed cells with chondroitinase ABC did not abolish Gal-1-cell near the lumenal surface of some samples. The progressive interactions (not shown). In order to estimate which of the increase in Gal-1 staining coincided with increasing exGal-1 interactions was more prominent, iodinated Gal FP pression of PCNA protein (Fig. 1) . Thus, Gal-1 was and GST were used to study Gal-1 binding to SMCs and to upregulated during SMC proliferation in coronary en-ECM produced by the same cells (Fig. 6 ). Gal-1 specific GST and Gal FP, used in the same molar concentrations. (compare Fig. 6A and 6B ). The Gal-1 specific binding to ECM was abolished by lactose, whereas Gal-1 binding to SMCs was stronger and reduced only by one-third in the 4. Discussion presence of lactose. A Scatchard plot of cell binding showed a non-linear curve, which indicated either the It has been shown recently that Gal-3, a b-galactosidepresence of different types of receptor sites for Gal-1 or binding 30 kDa lectin, is likely to be involved in the co-operative effects of ligand-receptor interactions (Fig. development of atherosclerosis, as it is expressed at 6C).
increased levels in human atherosclerotic lesions, rat aorta Since we found Gal-1 in ECM of atheroma fragments, after balloon injury and in hypercholesterolemic rabbits we studied the binding of Gal FP to the ECM proteins VN, [26, 27] . Here we present data on expression of another OSP and TSP, which are known to be expressed by SMCs lectin, Gal-1, in human atheromatous endarterectomy in atherosclerotic, but undetectable in normal blood vessamples exposed to serum. Upregulation of Gal-1 cosels. The ELISA experiments showed that Gal FP bound to incided with expression of PCNA protein, therefore the TSP and VN in a dose-dependent manner in the range upregulation of Gal-1 expression coincided with SMC 50-2500 ng (not shown). Gal FP also bound to OSP at proliferation in the atheroma fragments of blood vessels. lower levels (not shown). Since the values of the binding There is little information on the expression of Gal-1 depend on the temperature and time of ELISA procedures, gene. It was shown that the Gal-1 promoter is regulated by we compared Gal FP binding to several ECM proteins in the level of DNA methylation in several cell types, but parallel (Fig. 7) . Gal FP binding to the same amounts of Gal-1 expression in SM has not been studied [28] . Since ECM proteins was dose-dependent and in the order: LN.
we did not have sufficient amounts of tissue samples to cFN.TSP.pFN.VN.OSP. This binding was significantisolate RNA, we studied Gal-1 upregulation in cell culture. ly reduced by lactose.
Gal-1 mRNA levels were markedly increased in growing In an attempt to understand a potential function for GST; Peak 3 (right, shaded): antibodies1Gal FP. Horizontal axis:
Gal-1 in cell proliferation, we studied whether Gal-1 may fluorescence intensity. Vertical axis: cell number.
affect cell growth in cell culture. DNA synthesis of vascular SMCs, induced by serum, was enhanced on Gal FP-covered plastic compared with non-covered or GSTthat Gal FP did not have any mitogenic activity in serum covered plastic. Also, DNA synthesis on ECM produced free medium on plastic or ECM. As we showed previously, by SMCs was increased when ECM was treated with Gal the effect of Gal FP on cell adhesion is quite complicated: FP compared with non-treated or GST-treated ECM. The although SMCs attached to Gal FP-covered plastic, Gal FP increase of DNA synthesis induced by Gal FP was higher inhibited cell spreading, and thereby rearrangement of on plastic than on ECM, possibly because ECM bound cytoskeleton required for cell proliferation. Gal FP slightly only a small proportion of the applied Gal FP (Fig. 6 ). Gal increased cell attachment to ECM. Since the increase in FP did not affect DNA synthesis of PAC1 cells. The PAC1 cell adhesion induced by Gal FP was much lower than the SM cell line, which is able to carry out SM-specific increase in DNA synthesis, it seems unlikely that Gal FP splicing, maintains a differentiated SM phenotype and affects cell proliferation via increasing cell adhesion. We expresses large amounts of SM a-actin [21, 22] , is an infer that Gal FP-induced modulation of cell adhesion and immortal cell line indicating that cell cycle control is DNA synthesis may be independent events mediated via deregulated. The loss of responsiveness to the ECM different receptors and signalling pathways. signals, e.g. the presence of Gal-1, may indicate the Gal-1 has been shown to bind to ECM proteins as well differences between normal SMCs and the immortal PAC1 as to cellular receptors [29] [30] [31] [32] [33] [34] [35] . The proteins recognised cell line, and may relate to the growth requirements of by Gal-1 are cell type specific. In carcinoma cells, the normal vascular SMCs. main cellular proteins bound to Gal-1 were identified as The Gal-1 effect on DNA synthesis of SMCs may be Lamp-1 and Lamp-2, and carcinoma embryonic antigen caused either by direct stimulation by Gal-1 or by in- [33] [34] [35] . Gal-1 interacted with a7b1 and a1b1 integrins in creased adhesion mediated by Gal-1. Our data suggested skeletal myocytes and human SMCs, respectively [32, 11] .
in SMC extracts. Using flow cytometry, we detected direct interactions between SMCs and Gal FP, and the presence of Gal-1 receptors on the cell surface of SMCs. To estimate the main Gal-1 binding sites in SM, we compared the Gal-1 binding to SMCs and ECM produced by these cells in cell culture. Contrary to our expectations, the binding to SMC was 30-40-fold higher than to ECM. Scatchard plot of cell binding demonstrated the complexity of cell-Gal-1 interactions: either different types of cellular receptors were present on the cell surface or there was a co-operative effect of Gal-1-receptor binding. Gal-1 is known to have the highest affinity for acetyllactosaminecontaining polysaccharide chains of glycoproteins and proteoglycans, but it also binds to other sugar structures with lower affinity [29, 37] . Gal-1 exists in monomeric and dimeric forms. The dimer binds to carbohydrates with higher affinity than the monomer [37] . Crystallographic analysis revealed that Gal-1 dimers cross-link polysaccharide chains [38] . This cross-linking is thought to play an important role in Gal-1 involvement in different physiological phenomena [29, 38] . Gal FP may not form dimers via the Gal-1 N-terminus sequences responsible for dimerisation, as these sequences may be hidden inside N-GSTGal-1-C termini FP. However, the isolation procedure for GST FP is based on isolating active GST dimers which bind to substrate-linked beads [39, 40] . For these reasons Gal FP is likely to form dimers, although not via Gal-1 interactions, which implies that Gal FP can cross-link polysaccharide chains as native Gal-1 dimers. Altogether, it is more likely that there are high and low affinity interactions between Gal FP and SMCs via several cell surface receptors. Since Gal FP bound to LN and cFN and Gal-1 colocalised with them in ECM of human SMCs in cell culture [11] , these ECM proteins are likely to be responsible for some part of Gal-1 binding to ECM. As Gal-1 well as cFN, which is also upregulated in atherosclerotic blood vessels [44] , are likely to bind to endogenous Gal-1 Similarly, Gal-3, the other b-galactoside-binding lectin, in atheroma fragments. We found that ECM in cell culture was shown to associate with a1b1 integrin [36] . In retains fairly small amounts of Gal FP, however it should placenta, the major Gal-1 binding proteins were laminin be noted that SMCs in cell culture grow at much higher and fibronectin [31] . Laminin is the major Gal-1-binding density and are surrounded by much less ECM than in protein in muscle cells and several other cell types [29, 30] .
vivo. Hence, much more Gal-1 may be bound to ECM in We showed previously that Gal-1 inhibited SMC adhevessel wall, especially to ECM in atherosclerotic tissue, sion to LN by interacting with both cells and LN [11] , which contains additional Gal-1-binding ECM proteins. which indicated interactions between SMCs and Gal-1. We Gal-1 can be characterised as a truly matricellular also showed that Gal-FP bound to a1b1 integrins and LN protein, which serves as an adapter between cells and SMCs. It is feasible that during Gal-1 upregulation in vivo, the causes of restenosis and adverse remodelling. 
